Page last updated: 2024-12-05

3,5-dinitrobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-dinitrobenzoic acid : A member of the class of benzoic acids that is benzoic acid in which the hydrogens at positions 3 and 5 are replaced by nitro groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7433
CHEMBL ID118713
CHEBI ID73914
SCHEMBL ID132541
MeSH IDM0085884

Synonyms (51)

Synonym
einecs 202-751-1
ccris 3129
ai3-01801
nsc 8732
dinitrobenzoic acid
nsc8732
dnba
nsc-8732
3,5-dinitrobenzoic acid
3-carboxy-1,5-dinitrobenzene
99-34-3
inchi=1/c7h4n2o6/c10-7(11)4-1-5(8(12)13)3-6(2-4)9(14)15/h1-3h,(h,10,11
benzoic acid, 3,5-dinitro-
benzoic acid,3,5-dinitro mfc7 h4 n2 o6
STK317801
3,5-dinitrobenzoic acid, 99%
NCIOPEN2_008996
AC-5972
D0824
CHEMBL118713 ,
3,5-dinitro-benzoic acid
chebi:73914 ,
AKOS000118997
A846008
bdbm50405315
3,5-dnba
3,5-dinitrobenzenecarboxylic acid
CS-006/03892031
unii-4v3f9q018p
4v3f9q018p ,
ec 202-751-1
FT-0614716
BBL019137
AM20060766
AB00864
3,5-dinitrobenzoic acid [mi]
SCHEMBL132541
DTXSID7059195
3,5 dinitrobenzoic acid
W-100040
STR01728
F9995-1665
mfcd00007253
3,5-dinitrobenzoic acid, standard for quantitative nmr, tracecert(r)
3,5-dinitrobenzoic acid, suitable for photographic applications
3,5-dinitrobenzoic acid; 3,5-dinitrobenzoic acid; 3-carboxy-1,5-dinitrobenzene; dnba; nsc 8732
3,5-dinitrobenzoicacid
Z56869296
3,5-dinitrobenzoesa currencyure
Q223027
EN300-17056
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
nucleobase-containing compound metabolic processThiopurine S-methyltransferaseHomo sapiens (human)
xenobiotic metabolic processThiopurine S-methyltransferaseHomo sapiens (human)
methylationThiopurine S-methyltransferaseHomo sapiens (human)
xenobiotic catabolic processThiopurine S-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingThiopurine S-methyltransferaseHomo sapiens (human)
thiopurine S-methyltransferase activityThiopurine S-methyltransferaseHomo sapiens (human)
S-adenosyl-L-methionine bindingThiopurine S-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosolThiopurine S-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1605095Inhibition of N-terminal His6-sumo-tagged full length Staphylococcus aureus ClpP expressed in Escherichia coli BL2 (DE3) at 10 uM pre-incubated for 10 mins before Suc-LY-AMC addition and measured after 1 hr by fluorescence based assay relative to control2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
AID213093Inhibition of purified human kidney thiopurine methyltransferase (TPMT)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Thiopurine methyltransferase: structure-activity relationships for benzoic acid inhibitors and thiophenol substrates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (28.95)18.7374
1990's3 (7.89)18.2507
2000's9 (23.68)29.6817
2010's14 (36.84)24.3611
2020's1 (2.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.11 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index55.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]